abrdn Life Sciences Investors SEC filings HQL

abrdn Life Sciences Investors has 519 filings in SEC EDGAR's recent list, going back to Dec 13, 1995. The most recent current report (Form 8-K) was filed on Sep 12, 2023 (auditor change). The company's fiscal year ends on September 30.

abrdn Life Sciences Investors SEC filings
Form Description Filed Period
DEF 14A Proxy statement Apr 7, 2026 May 27, 2026
DEF 14A Proxy statement Apr 14, 2025 May 28, 2025
DEFA14A Additional proxy material May 24, 2024 —
DEF 14A Proxy statement Apr 22, 2024 Jun 25, 2024
DEFA14A Additional proxy material Oct 5, 2023 —
DEFA14A Additional proxy material Oct 4, 2023 —
DEFA14A Additional proxy material Oct 2, 2023 —
DEFA14A Additional proxy material Sep 15, 2023 —
DEFA14A Additional proxy material Sep 15, 2023 —
DEFA14A Additional proxy material Sep 13, 2023 —
DEFA14A Additional proxy material Sep 5, 2023 —
DEFA14A Additional proxy material Aug 29, 2023 —
DEFA14A Additional proxy material Aug 22, 2023 —
DEFA14A Additional proxy material Aug 14, 2023 —
DEFA14A Additional proxy material Aug 11, 2023 —
DEFA14A Additional proxy material Jul 28, 2023 —
DEFA14A Additional proxy material Jul 18, 2023 —
DEFA14A Additional proxy material Jul 11, 2023 —
DEF 14A Proxy statement Jul 10, 2023 Aug 14, 2023
PRE 14A Preliminary proxy statement Jun 27, 2023 Aug 14, 2023
DEF 14A Proxy statement Apr 11, 2023 Jun 8, 2023
DEFA14A Additional proxy material Apr 20, 2022 —
DEF 14A Proxy statement Apr 12, 2022 Jun 9, 2022
DEF 14A Proxy statement Apr 13, 2021 Jun 10, 2021
DEF 14A Proxy statement Apr 14, 2020 Jun 11, 2020
DEFA14A Additional proxy material Apr 15, 2019 —
DEF 14A Proxy statement Apr 15, 2019 Jun 13, 2019
DEFA14A Additional proxy material Apr 25, 2018 —
DEF 14A Proxy statement Apr 18, 2018 Jun 14, 2018
DEFA14A Additional proxy material May 26, 2017 —
DEFA14A Additional proxy material May 24, 2017 —
DEF 14A Proxy statement Apr 18, 2017 Jun 15, 2017
DEF 14A Proxy statement Apr 18, 2016 Jun 14, 2016
PRE 14A Preliminary proxy statement Apr 4, 2016 Jun 14, 2016
DEF 14A Proxy statement Apr 20, 2015 Jun 4, 2015
DEF 14A Proxy statement Apr 30, 2014 Jun 9, 2014
DEF 14A Proxy statement Apr 25, 2013 Jun 4, 2013
DEFA14A Additional proxy material Jun 4, 2012 —
DEFA14A Additional proxy material May 8, 2012 —
DEF 14A Proxy statement Apr 30, 2012 Jun 11, 2012
DEF 14A Proxy statement Jun 8, 2011 Jul 8, 2011
DEF 14A Proxy statement Mar 30, 2011 May 2, 2011
PRE 14A Preliminary proxy statement Mar 22, 2011 May 3, 2011
DEF 14A Proxy statement Apr 27, 2010 Jun 8, 2010
DEF 14A Proxy statement May 1, 2009 Jun 11, 2009
DEF 14A Proxy statement May 5, 2008 Jun 12, 2008
DEF 14A Proxy statement May 10, 2007 Jun 21, 2007
PRE 14A Preliminary proxy statement Apr 5, 2007 Jun 21, 2007
DEF 14A Proxy statement May 8, 2006 Jun 15, 2006
DEF 14A Proxy statement May 10, 2005 Jun 24, 2004
DEF 14A Proxy statement May 24, 2004 Jun 24, 2004
DEF 14A Proxy statement May 17, 2002 Jun 25, 2002
PRE 14A Preliminary proxy statement May 6, 2002 Jun 25, 2002
DEF 14A Proxy statement May 15, 2001 May 16, 2001
DEF 14A Proxy statement May 23, 2000 Jun 28, 2000
PRE 14A Preliminary proxy statement May 8, 2000 Jun 28, 2000
DEF 14A Proxy statement Apr 21, 1997 May 22, 1997

Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Listed as
HQL (NYSE)
Fiscal year ends
September 30
Incorporated in
MA
Headquarters
Philadelphia, PA
SEC CIK
884121
Former names
TEKLA LIFE SCIENCES INVESTORS (until Oct 5, 2023); H&Q LIFE SCIENCES INVESTORS (until Sep 18, 2014)

Source: SEC EDGAR filings. This is company-reported data, not investment advice.